Experimental Hematology
Volume 36, Issue 9 , Pages 1084-1090 , September 2008

AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice

  • Anna C. Pulliam

      Affiliations

    • Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Ind., USA
    • Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, Ind., USA
  • ,
  • M. Joe Hobson

      Affiliations

    • Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, Ind., USA
    • Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Ind., USA
  • ,
  • Samantha L. Ciccone

      Affiliations

    • Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Ind., USA
    • Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, Ind., USA
  • ,
  • Yan Li

      Affiliations

    • Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, Ind., USA
    • Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Ind., USA
  • ,
  • Shi Chen

      Affiliations

    • Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, Ind., USA
    • Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Ind., USA
  • ,
  • Edward F. Srour

      Affiliations

    • Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Ind., USA
    • Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Ind., USA
  • ,
  • Feng-Chun Yang

      Affiliations

    • Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, Ind., USA
    • Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Ind., USA
  • ,
  • Hal E. Broxmeyer

      Affiliations

    • Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Ind., USA
    • Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, Ind., USA
  • ,
  • D. Wade Clapp

      Affiliations

    • Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Ind., USA
    • Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, Ind., USA
    • Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Ind., USA
    • Corresponding Author InformationOffprint requests to: D. Wade Clapp, M.D., Cancer Research Center R4-402A, 1044 West Walnut Street, Indianapolis IN 46202

Received 30 January 2008 ,Revised 18 March 2008 ,Accepted 21 March 2008.

References 

  1. Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003;101:1249–1256
  2. Gluckman E, Rocha V. History of the clinical use of umbilical cord blood hematopoietic cells. Cytotherapy. 2005;7:219–227
  3. Gluckman E, Auerbach AD, Horowitz MM, et al. Bone marrow transplantation for Fanconi anemia. Blood. 1995;86:2856–2862
  4. Thompson LH. Unraveling the Fanconi anemia-DNA repair connection. Nat Genet. 2005;37:921–922
  5. Meetei AR, Sechi S, Wallisch M, et al. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol. 2003;23:3417–3426
  6. Levitus M, Rooimans MA, Steltenpool J, et al. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. Blood. 2004;103:2498–2503
  7. Meetei AR, Medhurst AL, Ling C, et al. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet. 2005;37:958–963
  8. Levitus M, Waisfisz Q, Godthelp BC, et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet. 2005;37:934–935
  9. Levran O, Attwooll C, Henry RT, et al. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet. 2005;37:931–933
  10. Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet. 2001;2:446–459
  11. Taniguchi T, Dandrea AD. Molecular pathogenesis of fanconi anemia. Int J Hematol. 2002;75:123–128
  12. Positional cloning of the Fanconi anaemia group A gene. The Fanconi anaemia/breast cancer consortium. Nat Genet. 1996;14:324–328
  13. de Winter JP, Leveille F, van Berkel CG, et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet. 2000;67:1306–1308
  14. de Winter JP, van der Weel L, de Groot J, et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet. 2000;9:2665–2674
  15. de Winter JP, Waisfisz Q, Rooimans MA, et al. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet. 1998;20:281–283
  16. Hejna JA, Timmers CD, Reifsteck C, et al. Localization of the Fanconi anemia complementation group D gene to a 200-kb region on chromosome 3p25.3. Am J Hum Genet. 2000;66:1540–1551
  17. Joenje H, Levitus M, Waisfisz Q, et al. Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A. Am J Hum Genet. 2000;67:759–762
  18. Joenje H, Oostra AB, Wijker M, et al. Evidence for at least eight Fanconi anemia genes. Am J Hum Genet. 1997;61:940–944
  19. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet. 1996;14:320–323
  20. Meetei AR, de Winter JP, Medhurst AL, et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet. 2003;35:165–170
  21. Pronk JC, Gibson RA, Savoia A, et al. Localisation of the Fanconi anaemia complementation group A gene to chromosome 16q24.3. Nat Genet. 1995;11:338–340
  22. Rahman N, Seal S, Thompson D, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet. 2007;39:165–167
  23. Reid S, Schindler D, Hanenberg H, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet. 2007;39:162–164
  24. Strathdee CA, Duncan AM, Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet. 1992;1:196–198
  25. Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature. 1992;358:434
  26. Timmers C, Taniguchi T, Hejna J, et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell. 2001;7:241–248
  27. Wevrick R, Clarke CA, Buchwald M. Cloning and analysis of the murine Fanconi anemia group C cDNA. Hum Mol Genet. 1993;2:655–662
  28. Whitney M, Thayer M, Reifsteck C, et al. Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p. Nat Genet. 1995;11:341–343
  29. Haneline LS, Gobbett TA, Ramani R, et al. Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. Blood. 1999;94:1–8
  30. Li X, Le Beau MM, Ciccone S, et al. Ex vivo culture of Fancc -/- stem/ progenitor cells predisposes cells to undergo apoptosis and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy. Blood. 2005;105:3465–3471
  31. Mohle R, Kanz L. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion. Semin Hematol. 2007;44:193–202
  32. Croop JM, Cooper R, Fernandez C, et al. Mobilization and collection of peripheral blood CD34+ cells from patients with Fanconi anemia. Blood. 2001;98:2917–2921
  33. Lapidot T, Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia. 2002;16:1992–2003
  34. Broxmeyer HE, Orschell CM, Clapp DW, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med. 2005;201:1307–1318
  35. Flomenberg N, Devine SM, Dipersio JF, et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood. 2005;106:1867–1874
  36. Haneline LS, Li X, Ciccone SL, et al. Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution. Blood. 2003;101:1299–1307
  37. Si Y, Ciccone S, Yang FC, et al. Continuous in vivo infusion of interferon-gamma (IFN-gamma) enhances engraftment of syngeneic wild-type cells in Fanca-/- and Fancg-/- mice. Blood. 2006;108:4283–4287
  38. Harrison DE. Competitive repopulation: a new assay for long-term stem cell functional capacity. Blood. 1980;55:77–81
  39. Carreau M, Gan OI, Liu L, Doedens M, Dick JE, Buchwald M. Hematopoietic compartment of Fanconi anemia group C null mice contains fewer lineage-negative CD34+ primitive hematopoietic cells and shows reduced reconstruction ability. Exp Hematol. 1999;27:1667–1674
  40. Robinson SN, Seina SM, Gohr JC, Sharp JG. Hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor and erythropoietin in the absence of matrix metalloproteinase-9. Stem Cells Dev. 2005;14:317–328
  41. Robinson SN, Pisarev VM, Chavez JM, Singh RK, Talmadge JE. Use of matrix metalloproteinase (MMP)-9 knockout mice demonstrates that MMP-9 activity is not absolutely required for G-CSF or Flt-3 ligand-induced hematopoietic progenitor cell mobilization or engraftment. Stem Cells. 2003;21:417–427
  42. Levesque JP, Liu F, Simmons PJ, et al. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood. 2004;104:65–72
  43. Pelus LM, Bian H, King AG, Fukuda S. Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRObeta/CXCL2 and GRObetaT/CXCL2delta4. Blood. 2004;103:110–119

PII: S0301-472X(08)00130-6

doi: 10.1016/j.exphem.2008.03.016

Experimental Hematology
Volume 36, Issue 9 , Pages 1084-1090 , September 2008